Archives

Data from OVATION 2 trial will also be reviewed in an oral presentation at ASCO Annual Meeting on June 3, 2025 LAWRENCEVILLE, N.J., May 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clin...

• May 06, 2025 05:05 AM PDT
• EODHD

JACKSONVILLE BEACH, Fla., May 6, 2025 (SEND2PRESS NEWSWIRE) -- Industrial SalesLeads released its April 2025 report on planned capital project spending in the Manufacturing construction industry, high...

• May 06, 2025 05:00 AM PDT
• Send2Press

Novo Nordisk A/S Data across obesity, cardiovascular disease, MASH, type 2 diabetes, as well as advances in obesity-related care to be presented at ECO 2025 – covering burden, and the value of treatme...

• May 06, 2025 05:00 AM PDT
• EODHD

WALTHAM, Mass., May 06, 2025--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive of...

• May 06, 2025 05:00 AM PDT
• EODHD

WOOD DALE, Ill., May 6, 2025 /PRNewswire/ -- AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, announced today that the Company's s...

• May 06, 2025 05:00 AM PDT
• EODHD

SAO PAULO (AP) — SAO PAULO (AP) — Embraer SA (ERJ) on Tuesday reported profit of $73.4 million in its first quarter. On a per-share basis, the Sao Paulo-based company said it had net income of 40 cent...

• May 06, 2025 04:56 AM PDT
• EODHD

(Reuters) -GlobalFoundries forecast second-quarter revenue and profit slightly above Wall Street estimates on Tuesday, in a sign that the contract chipmaker was seeing stable demand despite choppy aut...

• May 06, 2025 04:47 AM PDT
• EODHD

SAN DIEGO, May 06, 2025 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment o...

• May 06, 2025 04:30 AM PDT
• EODHD

WASHINGTON, May 06, 2025 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Scott Cockerham as a Senior Managing Director in the firm’s Corporate Finance & Restruc...

• May 06, 2025 04:30 AM PDT
• EODHD

GAITHERSBURG, Md., May 06, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company, today announced that it will report its first quarter 2025 financial...

• May 06, 2025 04:30 AM PDT
• EODHD